about
Epstein-Barr Virus: Diseases Linked to Infection and TransformationManagement of Viral Central Nervous System Infections: A Primer for CliniciansRole of the ubiquitin system and tumor viruses in AIDS-related cancer.The cycle of EBV infection explains persistence, the sizes of the infected cell populations and which come under CTL regulation.Treatment of HIV-related primary central nervous system lymphoma with AZT high dose, HAART, interleukin-2 and foscarnet in three patients.Frequency of Epstein - Barr Virus in Patients Presenting with Acute Febrile Illness in KenyaRecent advances in the understanding of infectious mononucleosis: are prospects improved for treatment or control?Activity and mechanism of action of HDVD, a novel pyrimidine nucleoside derivative with high levels of selectivity and potency against gammaherpesvirusesHsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein-Barr virus-infected cellsA case report of Epstein-Barr virus-associated retinal vasculitis: successful treatment using only acyclovir therapy.Development of drugs for Epstein-Barr virus using high-throughput in silico virtual screeningEpstein-Barr virus: novel patented therapeutics.Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.Designing an effective vaccine to prevent Epstein-Barr virus-associated diseases: challenges and opportunities.Maribavir inhibits Epstein-Barr virus transcription through the EBV protein kinase.Evaluation of novel acyclic nucleoside phosphonates against human and animal gammaherpesviruses revealed an altered metabolism of cyclic prodrugs upon Epstein-Barr virus reactivation in P3HR-1 cellsInhibitory activities of microalgal extracts against Epstein-Barr virus DNA release from lymphoblastoid cells.The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral productionMaribavir inhibits epstein-barr virus transcription in addition to viral DNA replicationResponse to valacyclovir in an HIV-infected girl with Epstein Barr infection.Concept and application of a computational vaccinology workflow.Biopsy-proven case of Epstein-Barr virus (EBV)-associated vasculitis of the central nervous system.Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients.Antiviral Drugs for EBV.
P2860
Q28074586-116289CB-3946-4FC7-91D8-C2953005C69FQ30145523-88A640ED-3C76-4237-B919-BFE615524188Q33307881-D173C686-4B8F-428D-ADD6-D1F5F28706BBQ35022301-E75A0660-9F40-46E6-8C01-177CED36DD49Q35959919-15C139B8-793E-4925-B655-72AAD0E9B9E6Q36013349-44C6C68B-B2E6-4963-B12F-59369B92E177Q36688962-E1E041EF-36C5-4F66-AD54-8F8800DC522AQ36759709-6BD4B42E-EA89-44D2-AE37-5BDB039EA0BAQ37123188-15E8BF10-47EF-4167-A33B-4971754BE729Q37138554-0A8645C6-226E-4C39-885F-64328DD8B887Q37278489-18CB4147-B6D0-487B-8956-4837855D112AQ37729167-52456DD8-6AA3-4A08-A91D-819FE0CB8ACFQ37849461-9BE5C199-5B5B-42E9-A658-85DC4B24A1D7Q39170011-92CD48D8-0360-40B0-82DA-47FF86B262EDQ39187112-0F128373-13D5-4606-A780-05A8CAB12B22Q39351834-C1D39BD4-1F7D-41B1-A816-2249F59FC960Q39551285-5817E6F9-ABDF-4403-9293-E6AD4811DA41Q39735571-2D18C8D4-CE59-4214-9CC6-FCA88B6F0498Q39798789-03D591A4-0D49-46C4-9CCD-ABA476067FF4Q40283396-B3DB1A9D-A795-42CE-95B8-1BA40596C1B0Q41848439-65F52790-83D4-4EF1-85EB-34269DDE3011Q45331358-8580D2A6-BC8E-44BC-B528-38D1A8686B44Q45360184-4C75353F-4360-4E30-ACBB-A9BC282A80EFQ55461330-0FD8899E-341E-4FF1-B0E5-7CFBBF9C8B84
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Epstein-Barr virus infections: prospects for treatment.
@ast
Epstein-Barr virus infections: prospects for treatment.
@en
Epstein-Barr virus infections: prospects for treatment.
@nl
type
label
Epstein-Barr virus infections: prospects for treatment.
@ast
Epstein-Barr virus infections: prospects for treatment.
@en
Epstein-Barr virus infections: prospects for treatment.
@nl
prefLabel
Epstein-Barr virus infections: prospects for treatment.
@ast
Epstein-Barr virus infections: prospects for treatment.
@en
Epstein-Barr virus infections: prospects for treatment.
@nl
P356
P1476
Epstein-Barr virus infections: prospects for treatment.
@en
P2093
Joseph S Pagano
P304
P356
10.1093/JAC/DKI240
P407
P577
2005-07-08T00:00:00Z